Company: CXDO
Filing Date: 2025-03-04
Form Type: 10-K
Source: 0001654954-25-002287
Chunk: 1021

Company: Crexendo, Inc.
Filing Date: 2025-03-04
Form: 10-K
Item: Item 7A
Chunk 1021
---
Stock options $2,399  $3,221 Restricted stock units  603   628 Total cost related to share-based compensation expense $3,002  $3,849 Share-based compensation expense by financial statement line item:        Cost of revenue $476  $582 Research and development  611   610 Selling and marketing  548   658 General and administrative  1,367   1,999 Total cost related to share-based compensation expense $3,002  $3,849  The tax benefit related to stock compensation expense on net deferred tax assets at December 31, 2024 and 2023 was $812 and $747, respectively. 

 73Table of Contents

15. Income Taxes The income tax benefit/(provision) consisted of the following for the years ended December 31, 2024 and 2023 (in thousands):     Year Ended December 31,   2024  2023 Current income taxes:      Federal $-  $- State and local  (169)  (98)Foreign  (43)  - Total current  (212)  (98)         Deferred income taxes:        Federal  -   - State and local  -   - Total deferred  -   -          Total income tax benefit/(provision) $(212) $(98) The income tax provision attributable to income before income tax benefit for the years ended December 31, 2024 and 2023 differed from the amounts computed by applying the U.S. federal statutory tax rate of 21%, as a result of the following (in thousands):   Year Ended December 31,   2024  2023 U.S. federal statutory income tax benefit/(provision) $(397) $56 Increase in income tax benefit resulting from:        State and local income tax benefit/(provision), net of federal effect  (135)  (69)Change in the valuation allowance for net deferred income tax assets  (246)  219 Stock-based compensation  595   (418)Other, net  (29)  114 Income tax benefit/(provision) $212) $(98)

 74Table of